The Potential Influence of Radiation-Induced Microenvironments in Neoplastic Progression

Journal of Mammary Gland Biology and Neoplasia

Volumn 3, Issue 2, 1998, Pages 165-175

  Barcellos Hoff, M H ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Carcinogenesis; Extracellular matrix; Ionizing radiation; Stromal epithelial interactions; Transforming growth factor

Indexed keywords

ANIMAL; BREAST; BREAST TUMOR; CELL TRANSFORMATION; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; MOUSE; NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER; PATHOPHYSIOLOGY; RADIATION EXPOSURE; RADIATION INJURY; REVIEW; UDDER;

NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; NEOPLASMS, RADIATION-INDUCED;

EID: 0032034449     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018794806635     Document Type: Article

References (75)

1. M. J. Bissell and M. H. Barcellos-Hoff (1987). The influence of extracellular matrix on gene expression: Is structure the message? J. Cell Sci. 8:327-343.
2. J. J. Decosse, C. L. Gossens, J. F. Kuzma, and D. Unsworth (1973). Breast cancer: Induction of differentiation by embryonic tissue. Science 181:1057-1058.
3. M. Cooper and H. Pinkus (1977). Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth. Cancer Res. 37:2544-2552.
4. K. Kamiya, J. Yasukawa-Barnes, J. M. Mitchen, M. N. Gould, and K. H. Clifton (1995). Evidence that carcinogenesis involves an imbalance between epigenetic high-frequency initiation and suppression of promotion. Proc. Natl. Acad. Sci. U.S.A. 92:1332-1336.
5. E. Farber (1984). Pre-cancerous steps in carcinogenesis. Their physiological adaptive nature. Biochem. Biophys. Acta 738:171-180.
6. H. Rubin (1985). Cancer as a dynamic developmental disorder. Cancer Res. 45:2935-2942.
7. M. H. Sieweke and M. J. Bissell (1994). The tumor promoting effect of wounding: A possible role for TGFβ induced fibrotic stroma. Crit. Rev. Oncogenesis 5(2/3):297-311.
8. M. H. Barcellos-Hoff, J. Aggeler, T. G. Ram, and M. J. Bissell (1989). Functional differentiation and alveolar morphogenesis of primary mammary epithelial cells cultures on reconstituted basement membrane. Development 105:223-235.
9. K. L. Schmeichel, V. M. Weaver, M. J. Bissell (1998). Structural cups from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype J. Mam. Gland Biol. Neoplasia 3:xx-xx.
10. G. Bauer (1996). Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis Histol. Histopathol. 11(1):237-255.
11. H. Fujii, G. R. Cunha, and J. T. Norman (1982). The induction of adenocarinomatous differentiation in neoplastic bladder epithelium by an embryonic prostatic inducer. J. Urology 128:858-861.
12. B. E. Elliott, L. Maxwell, M. Arnold, W. Z. Wei, and F. R. Miller (1988). Expression of epithelial-like markers and class I major histocompatibility antigens by a murine carcinoma growing in the mammary gland and in metastases: Orthotopic site effects. Cancer Res. 48:7237-7245.
13. T. Sakakura, Y. Sakagami, and Y. Nishizuka (1979). Acceleration of mammary cancer development by grafting of fetal mammary mesenchymes in C3H mice. Gann 70:459-466.
14. T. Sakakura, Y. Sakagami, and Y Nishizuka (1981). Accelerated mammary cancer development by fetal salivary mesenchyme isografted to adult mouse mammary epithelium. JNCI 66:953-959.
15. K. B. DeOme, M. J. Miyamoto, R. C. Osborn, R. C. Guzman, and K. Lum (1978). Detection of inapparent nodule transformed cells in the mammary gland tissues of virgin female BALB/ cfC3H mice. Cancer Res. 38:2103-2111.
16. S. P. Ethier and R. L. Ullrich (1984). Factors influencing expression of mammary ductal dysplasia in cell dissoication-derived murine mammary outgrowths. Cancer Res. 44:4523-4527.
17. A. van den Hoof, (1988). Stromal involvement in malignant growth. Adv. Cancer. Res. 50:159-196.
18. M. H. Sieweke, N. L. Thompson, M. B. Sporn, and M. J. Bissell (1990). Mediation of wound-related Rous sarcoma virus tumorigenesis and TGF-β. Science 248:1656-1660.
19. S. L. Schor, A. M. Schor, P. Durning, and G. Rushton (1985). Skin fibroblasts obtained from cancer patients display foetal-like migratory behavior on collagen gels. J. Cell Sci. 73:235-244.
20. J. A. Haggie, S. L. Schor, A. Howell, J. M. Birch, and R. A. S. Sellwood (1987). Fibroblasts from relatives of hereditary breast cancer patients display fetal-like behavior in vitro. Lancet 1:1455-1457.
21. L. Kopelovich, L. M. Pfeffer, and N. Bias (1979). Growth characteristics of human skin fibroblasts in vitro: A simple experimental approach for the identification of hereditary adenomatosis of the colon and rectum. Cancer 43:218-223.
22. S. Rasheed and M. B. Gardner (1981). Growth properties and susceptibility to viral transformation of skin fibroblasts from individuals at high genetic risk for colorectal cancer. JNCI 66:43-49.
23. G. M. Hodges, R. M. Hicks, and G. D. Spacey (1977). Epithelial-stromal interactions in normal and chemical carcinogen-treated adult bladder. Cancer Res. 37:3720-3730.
24. M. Martin, J. Remy, and F. Daburon (1986). In vitro growth potential of fibroblasts isolated from pigs with radiation-induced fibrosis. Int. J. Rad. Biol. 49:821-828.
25. R. G. Panizzoni, W. R. Hanson, D. E. Schwartz, and F. D. Malkinson (1988). Ionizing radiation induces early, sustained increases in collagen biosynthesis: A 48-week study of mouse skin and skin fibroblast cultures. Rad. Res. 116:145-156.
26. G. T. Bowden, D. Jaffe, and K. Andrews (1990). Biological and molecular aspects of radiation carcinogenesis in mouse skin. Rad. Res. 121:235-241.
27. L. A. Liotta, C. N. Rao, and S. H. Barsky (1983). Tumor invasion and the extracellular matrix. Lab. Invest. 49:636-649.
28. M. H. Barcellos-Hoff (1993). Radiation-induced transforming growth factor β and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res. 53:3880-3886.
29. D. P. Penney and W. A. Rosenkrans, Jr. (1984). Cell-cell matrix interactions in induced lung injury I. The effects of X-irradiation on basal laminar proteoglycans. Rad. Res. 99:410-419.
30. W. A. Rosenkrans, Jr. and D. P. Penney (1985). Cell-cell matrix interactions in induced lung injury II. x-irradiation mediated changes in specific basal laminar glycosaminoglycans. Int. J. Rad. Oncol. Biol. Phys. 11:1629-1637.
31. T. Sakakura, A. Ishihara, and R. Yatani (1991). Tenascin in mammary gland development: from embryogenesis to carcinogenesis. Cancer Treat. Res. 53:383-400.
32. E. J. Ehrhart, E. L. Gillette, and M. H. Barcellos-Hoff (1996). Immunohistochemical evidence of rapid extracellular matrix remodeling after iron-particle irradiation of mouse mammary gland. Rad. Res. 145: 157-162.
33. R. Sawaya, P. J. Tofilon, S. Mohanam, F. Ali-Osman, L. A. Liotta, W. G. Stetler-Stevenson, and J. S. Rao (1994). Induction of tissue-type plasminogen activator and 72 kDa type IV collagenase by ionizing radiation in rat astrocytes. Int. J. Cancer 56:214-218.
34. M. S. Stack, R. D. Gray, and S. V. Pizzo (1993). Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain. Cancer Res. 53(9):1998-2004.
35. S. G. Shaughnessy, M. Whaley, R. M. Lafrenie, and F. W. Orr (1993). Walker 256 tumor cell degradation of extracellular matrices involves a latent gelatinase activated by reactive oxygen species. Arch. Biochem. Biophys. 304(2):314-321.
36. G. P. Siegal, S. H. Barsky, V. P. Terranova, and L. A. Liotta (1981). Stages of neoplastic transformation of human breast tissue as monitored by dissolution of basement membrane components. An immunoperoxidase study. Invasion Metastasis 1:54-70.
37. W. Lewko, L. A. Liotta, M. S. Wicha, B. K. Vonderhaar, and W. R. Kidwell (1981). Sensitivity of N-nitrosomethylurea-induced rat mammary tumors to cis-hydroxyproline, an inhibitor of collagen production. Cancer Res. 41:2855-2862.
38. C. J. Sympson, M. J. Bissell, and Z. Werb (1995). Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. Sem. Cancer Biol. 6:159-163.
39. E. L. Alpen, P. Powers-Risius, S. B. Curtis, and R. DeGuzman (1993). Tumorigenic potential of high-Z, high LET charged-particle radiations. Rad. Res. 136:382-391.
40. K. Miyazono and C.-H. Heldin (1991). Latent forms of TGF-β: Molecular structure and mechanisms of activation. In G. R. Bock and J. Marsh (eds.), Clinical Applications of TGF-β. John Wiley, Chichester, pp. 81-92.
41. M. H. Barcellos-Hoff (1996). Latency and activation in the regulation of TGF-β. J. Mam. Gland Biol. Neoplasia 3(1):353-363.
42. G. H. Smith, (1996). TGF-β and functional differentiation. J. Mam. Gland Biol Neoplasia 1:343-352.
43. M. H. Barcellos-Hoff, R. Derynck, M. L. -S. Tsang, and J. A. Weatherbee (1994). Transforming growth factor-β activation in irradiated murine mammary gland. J. Clin. Invest. 93:892-899.
44. E. J. Ehrhart, A. Carroll, P. Segarini, M. L. -S. Tsang, and M. H. Barcellos-Hoff (1997). Latent transforming growth factor-β activation in situ: Quantitative and functional evidence following low dose irradiation. FASEB J. 11:991-1002.
45. A. B. Roberts, M. B. Sporn, R. K. Assoian, J. M. Smithe, N. S. Roche, L. M. Wakefield, U. I. Heine, L. A. Liotta, V. Falanga, J. H. Kehrl, and A. S. Fauci (1986). Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U.S.A. 83:4167-4171.
46. M. Reiss and M. H. Barcellos-Hoff (1997). Transforming growth factor-β in breast cancer: A working hypothesis. Br. Cancer Res. Treat. 45:81-95.
47. T. M. Fynan and M. Reiss (1993). Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Critical Rev. Oncogen. 4:493-540.
48. P. Barrett-Lee, M. Travers, Y. Luqmani, and R. C. Coombes (1990). Transcripts for transforming growth factors in human breast cancer: clinical correlates. Brit. J. Cancer 61:(4)612-617.
49. 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res. 52:4261-4264.
50. J. Godden, C. Porteous, W. D. George, and D. J. Kerr (1993). Bioassay of transforming gorwht factor-β activity in acidic protein extracts from primary breast cancer specimens. Anticancer Res. 13:427-431.
51. C. Knabbe, M. E. Lippman, L. M. Wakefield, K. C. Flanders, A. Dasid, R. Derynck, and R. B. Dickson (1987). Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428.
52. A. A. Colletta, L. M. Wakefield, F. V. Howell, D. Danielpour, M. Baum, and M. B. Sporn (1991). The growth inhibition of human breast cancer cells by a novel synthetic progestin involoves the induction of transforming growth factor beta. J. Clin. Invest. 87:277-283.
53. 1. Biochimica et Biophysica Acta 1137:116-120.
54. C. L. Arteaga, R. J. Coffey, T. C. Dugger, C. M. McCutchen, H. L. Moses, and R. M. Lyons (1990). Growth stimulation of human breast cancer cells with anti-transforming growth factor β antibodies: Evidence for negative autocrine regulation by transforming growth factor β. Cell Growth Differ. 1:367-374.
55. 1 levels during monoterpene-induced regresssion of mammary tumors. Cancer Res. 53:3849-3852.
56. D. R. Welch, A. Fabra, and M. Nakajima (1990). Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. PNAS 87:7678-7682.
57. J. D. Croxtall, A. Jamil, M. Ayub, A. A. Colletta, and J. O. White (1992). TGFβ stimulation of endometrial and breast-cancer cell growth. Int. J. Cancer 50:822-827.
58. 1 associates with disease progression in human breast cancer. Cancer Res. 52:6949-6952.
59. B. K. McCune, B. R. Mullin, K. C. Flanders, W. J. Jaffurs, L. T. Mullen, and M. B. Sporn (1992). Localization of transforming growth factor-β isotypes in lesions of the human breast. Human Pathol. 23(1):13-20.
60. 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am. J. Pathol. 143:381-389.
61. I. Wakefield, A. A. Colletta, B. K. McCune, and M. B. Sporn, Roles for transforming growth factors-β in the genesis, prevention and treatment of breast cancer. In R. B. Dickson and M. E. Lippman, (eds.), Genes, Oncogens, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer, Kluwer Academic Publishers, Boston, pp. 97-136.
62. 1 transgene expression. Proc. Natl. Acad. Sci. U.S.A. 92:4254-4258.
63. E. P. Bottinger, J. L. Jakubczak, D. C. Haines, K. Bagnall, and L. M. Wakefield (1997). Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor β receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimthylbenz[a]-anthracene. Cancer Res. 57:5564-5570.
64. W. Cui, D. J. Fowlis, S. Bryson, E. Duffie, H. Ireland, A. Balmain, and R. J. Akhurst (1996). TGF-β inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86(4):531-542.
65. R. A. Ignotz and J. Massague (1987). Cell adhesion protein receptors as targets for transforming growth factor-β action. Cell 51:189-197.
66. Y. Sato, F. Okada, M. Abe, T. Seguchi, M. Kuwano, S. Sato, A. Furuya, N. Hanai, and T. Tamaoki (1993). The mechanism for the activation of latent TGF-β during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-β to smooth muscle cells. J. Cell Biol. 123(5):1249-1254.
67. M. Terzaghi and P. Nettesheim (1979). Dynamics of neoplastic development in carcinogen-exposed tracheal mucosa. Cancer Res. 39:3004-3010.
68. R. J. M. Fry, R. D. Ley, D. Grube, and E. Staffeldt (1982). Studies on the multistage nature of radiation carcinogenesis. Carcinogen 7:155-165.
69. R. L. Ullrich and J. B. Storer (1979). Influence of gamma-irradiation on the development of neoplastic disease in mice. Rad. Res. 80:325-342.
70. R. L. Ullrich (1986). The rate of progression of radiation-transformed mammary epithelial cells is enhanced after low-dose-rate neutron irradiation. Rad. Res. 105:68-75.
71. R. Parsons, G. -M. Li, M. J. Longley, W. Fane, N. Papadopoulos, J. Jen, A. de la Chapelle, K. W. Kinzler, B. Vogelstein, and P. Modrich (1993). Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75:1227-1236.
72. R. Parsons, G. M. Li, M. Longley, P. Modrich, L. B., T. Berk, S. R. Hamilton, K. W. Kinzler, and B. Vogelstein (1995). Mismatch repair deficiency in phenotypically normal human cells. Science 268:738-740.
73. S. Markowitz, J. Wang, L. Myeroff, R. Parsons, L. Sun, R. S. Fan, E. Zborowska, K. W. Kinzler, B. Vogelstein, M. Brattain, and J. K. Willson (1995). Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338.
74. E. J. Bernhard, S. B. Gruber, and R. J. Muschel (1994). Direct evidence linking expression of matrix metalloproteinase 9(92kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. U.S.A. 91:4293-4297.
75. G. B. Silberstein and C. W. Daniel (1982). Elvax 40P implants, sustained local release of bioactive molecules influencing the mammary ductal development. Devel. Biol. 93:272-278.